Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis - Summary - MDSpire

Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis

  • By

  • Xingxuan Chen

  • Shibin Chen

  • Shuai Zhao

  • Yupeng Li

  • Jingkun Chang

  • Si Shi

  • Dandan Xu

  • Lijuan Li

  • Hong Chen

  • June 5, 2026

  • 0 min

Share

Objective:

To identify novel mechanism-based therapeutic targets for idiopathic pulmonary fibrosis (IPF) through multiomics analysis.

Key Findings:
  • Twelve proteins associated with IPF risk were identified, including eight pro-fibrotic mediators and four protective factors.
  • Prioritized candidate proteins include SCARF2 (protective), FN1, PPID, and CDON (pro-fibrotic).
  • Network analysis indicated FN1's role in extracellular matrix remodeling and SCARF2's role in immune regulation.
Interpretation:

Limitations:
  • The study relies on existing datasets, which may limit the generalizability of findings.
  • Further validation in clinical settings is necessary to confirm the therapeutic potential of identified targets.
Conclusion:

Original Source(s)

Identification of potential therapeutic targets for idiopathic pulmonary fibrosis: an integrated multiomics analysis

  • by Xingxuan Chen, Shibin Chen, Shuai Zhao, Yupeng Li, Jingkun Chang, Si Shi, Dandan Xu, Lijuan Li, Hong Chen

  • June 5, 2026

Related Content

Clinicopathological characteristics of alveolar adenoma

Optimizing drug combinations to resurrect the potency of failed antibody therapy against emerging COVID-19 variants using IDentif.AI

NHS-Galleri Linked to Delays

Analysis of England’s multicancer early detection screening trial found modest, temporary diagnostic delays in participating regions, adding to concerns about health system effects and the evidence base for population-level blood-based cancer screening.